Stay updated on DC/Myeloma Fusion+Nivolumab in Relapsed MM Clinical Trial

Sign up to get notified when there's something new on the DC/Myeloma Fusion+Nivolumab in Relapsed MM Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the DC/Myeloma Fusion+Nivolumab in Relapsed MM Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Removed the core disease term 'Multiple myeloma' and the related topic 'MedlinePlus Genetics' from the page. This reduces disease-specific context available to users seeking trial information on this condition.
    Difference
    0.2%
    Check dated 2026-03-28T02:58:48.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Site revision updated to v3.5.0; previous revision v3.4.3 was removed.
    Difference
    0.1%
    Check dated 2026-03-21T00:31:04.000Z thumbnail image
  4. Check
    28 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-06T18:36:13.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    Added related topics: Multiple Myeloma and MedlinePlus Genetics to the page.
    Difference
    0.2%
    Check dated 2026-02-20T15:09:51.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added to the page; the related topics 'Multiple myeloma' and 'MedlinePlus Genetics' were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-02-13T07:52:52.000Z thumbnail image
  8. Check
    64 days ago
    Change Detected
    Summary
    Revision: v3.4.1 has been added and Revision: v3.4.0 has been removed from the page's documents section.
    Difference
    0.1%
    Check dated 2026-02-05T18:57:05.000Z thumbnail image

Stay in the know with updates to DC/Myeloma Fusion+Nivolumab in Relapsed MM Clinical Trial

Enter your email address, and we'll notify you when there's something new on the DC/Myeloma Fusion+Nivolumab in Relapsed MM Clinical Trial page.